PharmaShots | Incisive News in 3 Shots

Subscribe Now

evaluate

Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSCLC

Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSC...

October 14, 2021

Asieris Receives NMPA's IND Approval to Evaluate APL-1202 + Tislelizumab as Neoadjuvant Therapy for MIBC Patients

Asieris Receives NMPA's IND Approval to Evaluate APL-1202 + Tislelizumab as Neoadjuvant Therapy for MIBC Patients

October 14, 2021

Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II Study for KRAS G12C-Mutated Lung Cancer

Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II S...

October 8, 2021

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

January 19, 2021

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

January 13, 2021

GSK and VIR Biotechnology to Evaluate VIR-7832 in the Early Treatment of COVID-19

GSK and VIR Biotechnology to Evaluate VIR-7832 in the Early Treatment of COVID-19

January 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us